0001493152-23-045524.txt : 20231220 0001493152-23-045524.hdr.sgml : 20231220 20231220094624 ACCESSION NUMBER: 0001493152-23-045524 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231220 DATE AS OF CHANGE: 20231220 EFFECTIVENESS DATE: 20231220 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Coya Therapeutics, Inc. CENTRAL INDEX KEY: 0001835022 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500218 FILM NUMBER: 231499679 BUSINESS ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 BUSINESS PHONE: 650.739.3939 MAIL ADDRESS: STREET 1: 12645 MEMORIAL DR., SUITE F1 #305 CITY: HOUSTON STATE: TX ZIP: 77024 D 1 primary_doc.xml X0708 D LIVE 0001835022 Coya Therapeutics, Inc. 5850 SAN FELIPE ST. SUITE 500 HOUSTON TX TEXAS 77057 650-739-3939 DELAWARE None None Corporation true 2020 Howard Berman 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Executive Officer Director Fred Grossman 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Executive Officer David Snyder 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Executive Officer Dieter Weinand 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Anabella Villalobos 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Ann Lee 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Hideki Garren 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Dov Goldstein 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Wilbur Ross 5850 San Felipe St. Suite 500 Houston TX TEXAS 77057 Director Biotechnology Decline to Disclose 06b false 2023-12-05 false true true true false 0 BTIG, LLC 122225 None None 600 MONTGOMERY STREET 6TH FLOOR SAN FRANCISCO CA CALIFORNIA 94111 All States false Newbridge Securities Corporation 104065 None None 1200 NORTH FEDERAL HIGHWAY SUITE 400 BOCA RATON FL FLORIDA 33432 All States false 26484515 26484515 0 false 122 0 true 0 The Company paid BTIG and Newbridge a fee based on gross proceeds from the sale of securities placed by each placement agent respectively and issued to Newbridge a warrant exercisable for 196,168 shares of Common Stock. 0 true Some of the proceeds may be used for working capital and general corporate purposes, including the payment of salaries and other fees to those listed in Item 3. false Coya Therapeutics, Inc. /s/ Howard Berman Howard Berman Chief Executive Officer 2023-12-20